Pharmacist Removed from Register for Supplying Codeine Linctus and Phenergan Without Clinical Justification
Date of Decision: May 24, 2024
Registrant's Role: Pharmacist
Allegations:
- Engaged in text conversations about supplying Codeine Linctus and Phenergan.
- Supplied or offered to supply these medicines without clinical need.
- Knew or believed they would be misused.
Outcome: Removal from the Register with interim suspension imposed
GPhC Standards Breached:
- Standard 5 – Using professional judgment
- Standard 6 – Behaving in a professional manner
- Standard 9 – Demonstrating leadership
Case Summary
The registrant, a pharmacist first registered in 2015, was employed at a London pharmacy. Concerns arose when another pharmacist (“Pharmacist 1”) was suspected of diverting medicines for misuse. Investigators discovered text message exchanges between Pharmacist 1 and the registrant, discussing the supply of Codeine Linctus and Phenergan.
These medicines, when combined, form a substance known as “Lean” or “Purple Drank,” which is abused recreationally. Given the known potential for misuse of these drugs, many pharmacies refuse to stock them. The registrant, however, repeatedly supplied these medicines upon request.
Investigation and Evidence
Continue Reading the Full Case
This case was published more than two weeks ago. A premium subscription is required to read the complete case summary.
- Full allegations considered by the GPhC/PSNI
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
The original determination document is available to registered users.